The story has been updated with the name of the investor. 

NEW YORK (360Dx) – VolitionRx today announced a definitive agreement for a private placement offering to raise $9 million in gross proceeds.

The deal is with existing accredited investor Cotterford Company. Under the terms of the agreement, VolitionRx is offering 5 million shares of its common stock at $1.80 per share, as well as a warrant to purchase up to an additional 5 million shares of the firm's stock at an exercise price of $3 per share payable in cash.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.